Deutsche Bank Ag\ Celldex Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 138,289 shares of CLDX stock, worth $2.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,289

Previous 121,501 13.82%

Holding current value

$2.81 Million

Previous $3.07 Million 18.27%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$18.15 - $27.6 $304,702 - $463,348	16,788 Added 13.82%	138,289 $2.51 Million
Q4 2024 Feb 14, 2025	BUY	$23.31 - $32.4 $1.91 Million - $2.66 Million	82,042 Added 207.92%	121,501 $3.07 Million
Q3 2024 Jun 26, 2025	SELL	$32.06 - $44.56 $3.17 Million - $4.4 Million	-98,830 Reduced 71.47%	39,459 $1.34 Million
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $161,069 - $223,869	-5,024 Reduced 11.29%	39,459 $1.34 Million
Q2 2024 Jun 12, 2025	SELL	$32.76 - $42.56 $3.07 Million - $3.99 Million	-93,806 Reduced 67.83%	44,483 $1.65 Million
Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $46,158 - $59,967	-1,409 Reduced 3.07%	44,483 $1.65 Million
Q1 2024 Jun 02, 2025	SELL	$35.22 - $51.88 $3.25 Million - $4.79 Million	-92,397 Reduced 66.81%	45,892 $1.93 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $337,301 - $496,854	9,577 Added 26.37%	45,892 $1.93 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $20,484 - $36,828	-906 Reduced 2.43%	36,315 $1.44 Million
Q3 2023 Nov 09, 2023	BUY	$25.45 - $37.46 $81,770 - $120,358	3,213 Added 9.45%	37,221 $1.02 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $336,824 - $425,673	-11,120 Reduced 24.64%	34,008 $1.15 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $306,237 - $417,621	8,805 Added 24.24%	45,128 $1.62 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $78,089 - $127,563	2,811 Added 8.39%	36,323 $1.62 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $3.1 Million - $5.14 Million	-136,702 Reduced 80.31%	33,512 $942,000
Q2 2022 Aug 11, 2022	BUY	$20.5 - $37.33 $1.95 Million - $3.56 Million	95,357 Added 127.39%	170,214 $4.59 Million
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $636,797 - $905,893	-23,039 Reduced 23.53%	74,857 $2.55 Million
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $1.88 Million - $2.96 Million	52,637 Added 116.3%	97,896 $3.78 Million
Q3 2021 Nov 04, 2021	BUY	$28.95 - $55.99 $307,680 - $595,061	10,628 Added 30.69%	45,259 $2.44 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $667,338 - $1.14 Million	32,223 Added 1338.16%	34,631 $1.16 Million
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $1.29 Million - $2.39 Million	-79,824 Reduced 97.07%	2,408 $49,000
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $4.68 Million - $7.1 Million	-312,041 Reduced 79.14%	82,232 $1.44 Million
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $3.8 Million - $5.99 Million	394,273 New	394,273 $5.85 Million

Others Institutions Holding CLDX

# of Institutions

188

Shares Held

69.3M

Call Options Held

220K

Put Options Held

310K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $949M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account